Therapy Management of Metastatic Prostate Carcinoma in General Practice

A Meisel - healthbook TIMES Oncology …, 2019 - onco-hema.healthbooktimes.org
The myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal
disorders caused by somatic driver mutations affecting the hematopoietic stem and …

[HTML][HTML] Advancing Ovarian Cancer Treatment: The Latest Insights on PARP Inhibitors from ASCO 2023

Y van Roon, M Vetter - healthbook …, 2023 - onco-hema.healthbooktimes.org
Ovarian cancer (OC) belongs to the most common malignancies in women and remains the
leading cause of mortality among gynecological cancers. Poly (ADP-ribose) polymerase …